Evidence map›Paper›PMID 23483349›Full record

ArticleAnnals of laboratory medicine2013

CTX-M-55-type extended-spectrum β-lactamase-producing Shigella sonnei isolated from a Korean patient who had travelled to China.

Wonmok Lee, Hae-Sun Chung, Hyukmin Lee, Jong Hwa Yum, Dongeun Yong, Seok Hoon Jeong, Kyungwon Lee, Yunsop Chong

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Annals of laboratory medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Fecal Shedding of Multidrug ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  3. Travel-Related Antimicrobial Resistance: A Systematic Review.Tropical medicine and infectious disease · 2021
    Review
  4. Article
  5. Prolonged Outbreak of Multidrug-Resistant Shigella sonnei HarboringAntimicrobial agents and chemotherapy · 2020
    Article
  6. Review
  7. Observational
  8. Article
  9. Increasing clinical resistance rate ofAnnals of translational medicine · 2018
    Article
  10. Article
  11. Common findings of blaCurrent microbiology · 2017
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Wonmok LeeDepartment of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea.
Hae-Sun Chung
Hyukmin Lee
Jong Hwa Yum
Dongeun Yong
Seok Hoon Jeong
Kyungwon Lee
Yunsop Chong
Yonsei University · KRCatholic Kwandong University · KRDong-Eui University · KREwha Womans University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of CTX-M-55-type extended-spectrum β-lactamase (ESBL)-producing Shigella sonnei infection in a 27-year-old Korean woman who had traveled to China. The patient was admitted to the hospital due to abdominal pain, watery diarrhea, and fever (39.3℃). S. sonnei was isolated from her stool specimens, and the pathogen was found to be resistant to cefotaxime due to CTX-M-55-type ESBL. Insertion sequence (IS)Ecp1 was found upstream of the blaCTX-M-55 gene. The blaCTX-M-55 gene was transferred from the S. sonnei isolate to an Escherichia coli J53 recipient by conjugation. Pulsed-field gel electrophoresis and Southern blotting revealed that the blaCTX-M-55 gene was located on a plasmid of approximately 130 kb.

Indexed as

AdultAnti-Bacterial AgentsAsian Peoplebeta-LactamasesCefotaximeChinaDrug Resistance, BacterialDysentery, BacillaryElectrophoresis, Gel, Pulsed-FieldEscherichia coliFecesFemaleHumansPlasmidsRepublic of KoreaShigella sonneiAnti-Bacterial Agentsbeta-LactamasesCefotaximeCTX-M-55ESBLShigella sonnei

Identifiers

PMID23483349
PMCPMC3589641
OpenAlexW2159913823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.